VHT holdings
Vanguard Health Care ETF
Positions
407 stored of 407 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 301 | SI-BONE Inc | US8257041090 | 825704109 | 0.009% | $1.7M | Equity (common) | Corporate | United States | USD |
| 302 | CytomX Therapeutics Inc | US23284F1057 | 23284F105 | 0.009% | $1.7M | Equity (common) | Corporate | United States | USD |
| 303 | Altimmune Inc | US02155H2004 | 02155H200 | 0.009% | $1.7M | Equity (common) | Corporate | United States | USD |
| 304 | Sana Biotechnology Inc | US7995661045 | 799566104 | 0.009% | $1.7M | Equity (common) | Corporate | United States | USD |
| 305 | Janux Therapeutics Inc | US47103J1051 | 47103J105 | 0.009% | $1.7M | Equity (common) | Corporate | United States | USD |
| 306 | Mesa Laboratories Inc MESA LABS | US59064R1095 | 59064R109 | 0.009% | $1.7M | Equity (common) | Corporate | United States | USD |
| 307 | Tactile Systems Technology Inc | US87357P1003 | 87357P100 | 0.009% | $1.7M | Equity (common) | Corporate | United States | USD |
| 308 | Allogene Therapeutics Inc | US0197701065 | 019770106 | 0.009% | $1.6M | Equity (common) | Corporate | United States | USD |
| 309 | Ironwood Pharmaceuticals Inc | US46333X1081 | 46333X108 | 0.008% | $1.6M | Equity (common) | Corporate | United States | USD |
| 310 | Maravai LifeSciences Holdings Inc MARAVAI LIFESC-A | US56600D1072 | 56600D107 | 0.008% | $1.6M | Equity (common) | Corporate | United States | USD |
| 311 | Pulse Biosciences Inc | US74587B1017 | 74587B101 | 0.008% | $1.5M | Equity (common) | Corporate | United States | USD |
| 312 | Olema Pharmaceuticals Inc | US68062P1066 | 68062P106 | 0.008% | $1.5M | Equity (common) | Corporate | United States | USD |
| 313 | ARS Pharmaceuticals Inc | US82835W1080 | 82835W108 | 0.008% | $1.5M | Equity (common) | Corporate | United States | USD |
| 314 | Arvinas Inc | US04335A1051 | 04335A105 | 0.008% | $1.5M | Equity (common) | Corporate | United States | USD |
| 315 | Cullinan Therapeutics Inc | US2300311063 | 230031106 | 0.008% | $1.4M | Equity (common) | Corporate | United States | USD |
| 316 | Emergent BioSolutions Inc | US29089Q1058 | 29089Q105 | 0.008% | $1.4M | Equity (common) | Corporate | United States | USD |
| 317 | AngioDynamics Inc | US03475V1017 | 03475V101 | 0.008% | $1.4M | Equity (common) | Corporate | United States | USD |
| 318 | MeiraGTx Holdings plc | KYG596651029 | G59665102 | 0.007% | $1.4M | Equity (common) | Corporate | United States | USD |
| 319 | Prothena Corp PLC | IE00B91XRN20 | G72800108 | 0.007% | $1.4M | Equity (common) | Corporate | United States | USD |
| 320 | Cytek Biosciences Inc | US23285D1090 | 23285D109 | 0.007% | $1.4M | Equity (common) | Corporate | United States | USD |
| 321 | Phathom Pharmaceuticals Inc | US71722W1071 | 71722W107 | 0.007% | $1.3M | Equity (common) | Corporate | United States | USD |
| 322 | Tyra Biosciences Inc | US90240B1061 | 90240B106 | 0.007% | $1.3M | Equity (common) | Corporate | United States | USD |
| 323 | Kestra Medical Technologies In | BMG524411052 | G52441105 | 0.007% | $1.3M | Equity (common) | Corporate | United States | USD |
| 324 | MiMedx Group Inc | US6024961012 | 602496101 | 0.007% | $1.3M | Equity (common) | Corporate | United States | USD |
| 325 | Varex Imaging Corp | US92214X1063 | 92214X106 | 0.007% | $1.3M | Equity (common) | Corporate | United States | USD |
| 326 | Ocugen Inc | US67577C1053 | 67577C105 | 0.007% | $1.3M | Equity (common) | Corporate | United States | USD |
| 327 | 4D Molecular Therapeutics Inc | US35104E1001 | 35104E100 | 0.007% | $1.3M | Equity (common) | Corporate | United States | USD |
| 328 | XOMA Royalty Corp | US98419J2069 | 98419J206 | 0.007% | $1.2M | Equity (common) | Corporate | United States | USD |
| 329 | Replimune Group Inc | US76029N1063 | 76029N106 | 0.006% | $1.2M | Equity (common) | Corporate | United States | USD |
| 330 | Lexicon Pharmaceuticals Inc | US5288723027 | 528872302 | 0.006% | $1.2M | Equity (common) | Corporate | United States | USD |
| 331 | Cross Country Healthcare Inc | US2274831047 | 227483104 | 0.006% | $1.2M | Equity (common) | Corporate | United States | USD |
| 332 | Pacific Biosciences of California Inc | US69404D1081 | 69404D108 | 0.006% | $1.1M | Equity (common) | Corporate | United States | USD |
| 333 | Perspective Therapeutics Inc | US46489V3024 | 46489V302 | 0.006% | $1.1M | Equity (common) | Corporate | United States | USD |
| 334 | Evolent Health Inc EVOLENT HEALTH-A | US30050B1017 | 30050B101 | 0.006% | $1.1M | Equity (common) | Corporate | United States | USD |
| 335 | Aveanna Healthcare Holdings Inc | US05356F1057 | 05356F105 | 0.006% | $1.1M | Equity (common) | Corporate | United States | USD |
| 336 | Myriad Genetics Inc | US62855J1043 | 62855J104 | 0.006% | $1.1M | Equity (common) | Corporate | United States | USD |
| 337 | ORIC Pharmaceuticals Inc | US68622P1093 | 68622P109 | 0.006% | $1.1M | Equity (common) | Corporate | United States | USD |
| 338 | Vanda Pharmaceuticals Inc | US9216591084 | 921659108 | 0.006% | $1.1M | Equity (common) | Corporate | United States | USD |
| 339 | Fulgent Genetics Inc | US3596641098 | 359664109 | 0.006% | $1.1M | Equity (common) | Corporate | United States | USD |
| 340 | Savara Inc | US8051111016 | 805111101 | 0.006% | $1.1M | Equity (common) | Corporate | United States | USD |
| 341 | Community Health Systems Inc | US2036681086 | 203668108 | 0.005% | $1.0M | Equity (common) | Corporate | United States | USD |
| 342 | Bioventus Inc BIOVENTUS - A | US09075A1088 | 09075A108 | 0.005% | $1.0M | Equity (common) | Corporate | United States | USD |
| 343 | Editas Medicine Inc | US28106W1036 | 28106W103 | 0.005% | $1.0M | Equity (common) | Corporate | United States | USD |
| 344 | Ceribell Inc | US15678C1027 | 15678C102 | 0.005% | $1.0M | Equity (common) | Corporate | United States | USD |
| 345 | Septerna Inc | US81734D1046 | 81734D104 | 0.005% | $1.0M | Equity (common) | Corporate | United States | USD |
| 346 | Ginkgo Bioworks Holdings Inc | US37611X2099 | 37611X209 | 0.005% | $971K | Equity (common) | Corporate | United States | USD |
| 347 | Prime Medicine Inc | US74168J1016 | 74168J101 | 0.005% | $956K | Equity (common) | Corporate | United States | USD |
| 348 | Evolus Inc | US30052C1071 | 30052C107 | 0.005% | $940K | Equity (common) | Corporate | United States | USD |
| 349 | REGENXBIO Inc | US75901B1070 | 75901B107 | 0.005% | $908K | Equity (common) | Corporate | United States | USD |
| 350 | OrthoPediatrics Corp | US68752L1008 | 68752L100 | 0.005% | $895K | Equity (common) | Corporate | United States | USD |
| 351 | Simulations Plus Inc | US8292141053 | 829214105 | 0.005% | $887K | Equity (common) | Corporate | United States | USD |
| 352 | Zenas Biopharma Inc | US98937L1052 | 98937L105 | 0.005% | $878K | Equity (common) | Corporate | United States | USD |
| 353 | Orthofix Medical Inc | US68752M1080 | 68752M108 | 0.005% | $872K | Equity (common) | Corporate | United States | USD |
| 354 | Standard BioTools Inc | US34385P1084 | 34385P108 | 0.004% | $852K | Equity (common) | Corporate | United States | USD |
| 355 | OraSure Technologies Inc | US68554V1089 | 68554V108 | 0.004% | $842K | Equity (common) | Corporate | United States | USD |
| 356 | Fate Therapeutics Inc | US31189P1021 | 31189P102 | 0.004% | $831K | Equity (common) | Corporate | United States | USD |
| 357 | Anavex Life Sciences Corp | US0327973006 | 032797300 | 0.004% | $806K | Equity (common) | Corporate | United States | USD |
| 358 | Ardent Health Partners Inc ARDENT HEALTH IN | US03980N1072 | 03980N107 | 0.004% | $785K | Equity (common) | Corporate | United States | USD |
| 359 | Fulcrum Therapeutics Inc | US3596161097 | 359616109 | 0.004% | $780K | Equity (common) | Corporate | United States | USD |
| 360 | Akebia Therapeutics Inc | US00972D1054 | 00972D105 | 0.004% | $767K | Equity (common) | Corporate | United States | USD |
| 361 | Rocket Pharmaceuticals Inc | US77313F1066 | 77313F106 | 0.004% | $744K | Equity (common) | Corporate | United States | USD |
| 362 | GoodRx Holdings Inc GOODRX HOLDIN-A | US38246G1085 | 38246G108 | 0.004% | $741K | Equity (common) | Corporate | United States | USD |
| 363 | Atea Pharmaceuticals Inc | US04683R1068 | 04683R106 | 0.004% | $718K | Equity (common) | Corporate | United States | USD |
| 364 | Rezolute Inc | US76200L3096 | 76200L309 | 0.004% | $715K | Equity (common) | Corporate | United States | USD |
| 365 | OmniAb Inc | US68218J1034 | 68218J103 | 0.004% | $695K | Equity (common) | Corporate | United States | USD |
| 366 | First Tracks Biotherapeutics Inc | US3371851029 | 337185102 | 0.004% | $667K | Equity (common) | Corporate | United States | USD |
| 367 | Quantum-Si Inc | US74765K1051 | 74765K105 | 0.003% | $642K | Equity (common) | Corporate | United States | USD |
| 368 | Arcturus Therapeutics Holdings Inc | US03969T1097 | 03969T109 | 0.003% | $618K | Equity (common) | Corporate | United States | USD |
| 369 | Humacyte Inc | US44486Q1031 | 44486Q103 | 0.003% | $617K | Equity (common) | Corporate | United States | USD |
| 370 | MacroGenics Inc | US5560991094 | 556099109 | 0.003% | $609K | Equity (common) | Corporate | United States | USD |
| 371 | Upstream Bio Inc | US91678A1079 | 91678A107 | 0.003% | $606K | Equity (common) | Corporate | United States | USD |
| 372 | SIGA Technologies Inc SIGA TECH INC | US8269171067 | 826917106 | 0.003% | $605K | Equity (common) | Corporate | United States | USD |
| 373 | Zentalis Pharmaceuticals Inc | US98943L1070 | 98943L107 | 0.003% | $602K | Equity (common) | Corporate | United States | USD |
| 374 | Embecta Corp | US29082K1051 | 29082K105 | 0.003% | $571K | Equity (common) | Corporate | United States | USD |
| 375 | Verastem Inc | US92337C2035 | 92337C203 | 0.003% | $556K | Equity (common) | Corporate | United States | USD |
| 376 | RxSight Inc | US78349D1072 | 78349D107 | 0.003% | $553K | Equity (common) | Corporate | United States | USD |
| 377 | Keros Therapeutics Inc | US4923271013 | 492327101 | 0.003% | $553K | Equity (common) | Corporate | United States | USD |
| 378 | Accendra Health Inc | US6907321029 | 690732102 | 0.003% | $523K | Equity (common) | Corporate | United States | USD |
| 379 | Treace Medical Concepts Inc | US89455T1097 | 89455T109 | 0.003% | $521K | Equity (common) | Corporate | United States | USD |
| 380 | Alector Inc | US0144421072 | 014442107 | 0.003% | $495K | Equity (common) | Corporate | United States | USD |
| 381 | Organogenesis Holdings Inc | US68621F1021 | 68621F102 | 0.003% | $486K | Equity (common) | Corporate | United States | USD |
| 382 | Multiplan Corp CLARITEV CORP | US62548M2098 | 62548M209 | 0.002% | $432K | Equity (common) | Corporate | United States | USD |
| 383 | Entrada Therapeutics Inc | US29384C1080 | 29384C108 | 0.002% | $404K | Equity (common) | Corporate | United States | USD |
| 384 | Lyell Immunopharma Inc | US55083R2031 | 55083R203 | 0.002% | $397K | Equity (common) | Corporate | United States | USD |
| 385 | Quanterix Corp | US74766Q1013 | 74766Q101 | 0.002% | $381K | Equity (common) | Corporate | United States | USD |
| 386 | MaxCyte Inc | US57777K1060 | 57777K106 | 0.002% | $365K | Equity (common) | Corporate | United States | USD |
| 387 | Heron Therapeutics Inc | US4277461020 | 427746102 | 0.002% | $362K | Equity (common) | Corporate | United States | USD |
| 388 | Neumora Therapeutics Inc | US6409791000 | 640979100 | 0.002% | $333K | Equity (common) | Corporate | United States | USD |
| 389 | Korro Bio Inc | US5009461089 | 500946108 | 0.002% | $292K | Equity (common) | Corporate | United States | USD |
| 390 | LENZ Therapeutics Inc | US52635N1037 | 52635N103 | 0.001% | $271K | Equity (common) | Corporate | United States | USD |
| 391 | Aldeyra Therapeutics Inc | US01438T1060 | 01438T106 | 0.001% | $271K | Equity (common) | Corporate | United States | USD |
| 392 | Health Catalyst Inc | US42225T1079 | 42225T107 | 0.001% | $220K | Equity (common) | Corporate | United States | USD |
| 393 | Filana Therapeutics Inc | US14817C1071 | 14817C107 | 0.001% | $203K | Equity (common) | Corporate | United States | USD |
| 394 | Pliant Therapeutics Inc | US7291391057 | 729139105 | 0.001% | $193K | Equity (common) | Corporate | United States | USD |
| 395 | ALX Oncology Holdings Inc | US00166B1052 | 00166B105 | <0.001% | $185K | Equity (common) | Corporate | United States | USD |
| 396 | DocGo Inc | US2560861096 | 256086109 | <0.001% | $171K | Equity (common) | Corporate | United States | USD |
| 397 | TRS:JOHNSON & JOHNSON USD 2027-Jan-29 | Not reported | Not reported | −<0.001% | -$138K | Equity derivatives | Other | Not stated | USD |
| 398 | Gossamer Bio Inc | US38341P1021 | 38341P102 | <0.001% | $125K | Equity (common) | Corporate | United States | USD |
| 399 | Definitive Healthcare Corp | US24477E1038 | 24477E103 | <0.001% | $105K | Equity (common) | Corporate | United States | USD |
| 400 | TRS:ELEVANCE HEALTH INC USD 2027-Jan-29 | Not reported | Not reported | −<0.001% | -$44K | Equity derivatives | Other | Not stated | USD |